CVS blows past estimates, hikes guidance as insurance unit continues to improve

CVS Health reported strong second-quarter results that exceeded Wall Street expectations across all three of its business segments, prompting the company to increase its full-year financial guidance on Wednesday. The healthcare company now projects adjusted profit between $7.90 and $8.10 per share for 2026, up from prior guidance of $7.30 to $7.50 per share. Revenue expectations were also raised to at least $414 billion from the previous outlook of at least $405 billion.
Despite the robust earn